NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $554,527 | -1.6% | 5,492 | -0.7% | 0.03% | -9.4% |
| Q3 2023 | $563,286 | +0.9% | 5,530 | 0.0% | 0.03% | +10.3% |
| Q2 2023 | $558,032 | +681.1% | 5,530 | -12.2% | 0.03% | +20.8% |
| Q4 2022 | $71,444 | -84.7% | 6,299 | +14.2% | 0.02% | -22.6% |
| Q3 2022 | $466,000 | 0.0% | 5,514 | 0.0% | 0.03% | 0.0% |
| Q2 2022 | $466,000 | -3.7% | 5,514 | 0.0% | 0.03% | +14.8% |
| Q1 2022 | $484,000 | +0.4% | 5,514 | 0.0% | 0.03% | 0.0% |
| Q4 2021 | $482,000 | +6.9% | 5,514 | 0.0% | 0.03% | -3.6% |
| Q3 2021 | $451,000 | -10.3% | 5,514 | 0.0% | 0.03% | -12.5% |
| Q2 2021 | $503,000 | +6.8% | 5,514 | 0.0% | 0.03% | 0.0% |
| Q1 2021 | $471,000 | -10.6% | 5,514 | -1.3% | 0.03% | -15.8% |
| Q4 2020 | $527,000 | +7.3% | 5,584 | -1.1% | 0.04% | -5.0% |
| Q3 2020 | $491,000 | -0.4% | 5,647 | 0.0% | 0.04% | -7.0% |
| Q2 2020 | $493,000 | +8.1% | 5,647 | +2.1% | 0.04% | -4.4% |
| Q1 2020 | $456,000 | -12.3% | 5,532 | +0.7% | 0.04% | +2.3% |
| Q4 2019 | $520,000 | +26.5% | 5,494 | +16.0% | 0.04% | 0.0% |
| Q3 2019 | $411,000 | -4.9% | 4,735 | 0.0% | 0.04% | -6.4% |
| Q2 2019 | $432,000 | -5.1% | 4,735 | 0.0% | 0.05% | -6.0% |
| Q1 2019 | $455,000 | +12.1% | 4,735 | 0.0% | 0.05% | +4.2% |
| Q4 2018 | $406,000 | -1.2% | 4,735 | -0.6% | 0.05% | +4.3% |
| Q3 2018 | $411,000 | +14.2% | 4,765 | 0.0% | 0.05% | +7.0% |
| Q2 2018 | $360,000 | +7.1% | 4,765 | +14.8% | 0.04% | +2.4% |
| Q1 2018 | $336,000 | -42.9% | 4,150 | -40.8% | 0.04% | -40.0% |
| Q4 2017 | $588,000 | -4.7% | 7,007 | -2.6% | 0.07% | -9.1% |
| Q3 2017 | $617,000 | +4.4% | 7,192 | +1.5% | 0.08% | -2.5% |
| Q2 2017 | $591,000 | +20.6% | 7,085 | +7.5% | 0.08% | +16.2% |
| Q1 2017 | $490,000 | +13.4% | 6,593 | +11.2% | 0.07% | +17.2% |
| Q4 2016 | $432,000 | +2.1% | 5,929 | +10.6% | 0.06% | -1.7% |
| Q3 2016 | $423,000 | +3.4% | 5,362 | +8.1% | 0.06% | +3.5% |
| Q2 2016 | $409,000 | +25.5% | 4,958 | +10.2% | 0.06% | +21.3% |
| Q1 2016 | $326,000 | +8.3% | 4,499 | +28.6% | 0.05% | +4.4% |
| Q4 2015 | $301,000 | – | 3,498 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |